Health
Sandoz launches affordable iron sucrose injection for treatment of iron deficiency anemia in patients with chronic kidney disease in US
PRINCETON, N.J., September 24, 2025--Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio.
About this update from Sandoz Group Ltd
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3317,"height":450,"url":"https://media.zenfs.com/en/business-wire.com/ef80536e90cfd7411aa7f671871a4e54"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AIU.eJD0BPuRkdqlep5mVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/ef80536e90cfd7411aa7f671871a4e54","width":960,"height":130},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/sDfTLmM5fBN7v5n.UWEg3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMjY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/ef80536e90cfd7411aa7f671871a4e54","width":1200,"height":163}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Expands access to much-needed iron therapy for millions of US patients","length":70,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches","length":100,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Strengthens US supply of injectable iron sucrose","length":48,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":218,"olType":false},{"type":"text","content":"PRINCETON, N.J., September 24, 2025--(BUSINESS WIRE)--Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio.","length":446,"tagName":"p"},{"type":"text","content":"Intravenous iron sucrose is a cornerstone therapy for iron deficiency anemia, which impacts approximately five million US patients. This includes those with chronic kidney disease (CKD stages 3-5), which puts nearly 19 million Americans at high risk for anemia2-5. It is administered at dialysis centers nationwide, providing essential iron replacement to foster red blood cell production. Iron sucrose is approved to treat all indications of the reference medicine, Venofer®*6.","length":478,"tagName":"p"},{"type":"text","content":""Our launch of iron sucrose proves again th...